Zura Bio
Shannon Kenealy Carter is the Senior Vice President, Legal at Zura Bio Limited. Prior to this role, Shannon held various positions at Arena Pharmaceuticals, Inc., where she worked as the Vice President of Intellectual Property & Deputy General Counsel, Vice President of Intellectual Property, Head of Intellectual Property, Senior Director of Intellectual Property, Senior Intellectual Property Counsel, and Intellectual Property Counsel. Shannon began her legal career as an Associate at Knobbe Martens Olson & Bear LLP. Shannon holds a Juris Doctor (J.D.) from Stanford Law School, a Doctor of Philosophy (Ph.D.) in Human Genetics from Vanderbilt University, and a Bachelor's Degree from the University of Iowa.
Zura Bio
1 followers
Zura Bio is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. Currently, Zura Bio is developing three assets which have completed phase 1/1b studies and are Phase 2 ready. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), torudokimab (ZB-880), and ZB-168 with a goal of demonstrating their efficacy, safety, and dosing convenience in immune and inflammatory disorders. Zura Bio is headquartered in Henderson, NV with team members in the UK and USA.